Cellino's iPSC Manufacturing Technology Receives FDA Advanced Manufacturing Technology (AMT) Designation
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Cellino, a leader in advanced biomanufacturing, today announced that its optical biomanufacturing technology for generating induced pluripotent stem cells (iPSCs) has received the FDA's Advanced Manufacturing Technology (AMT) designation from the Center for Biologics Evaluation and Research (CBER). This prestigious designation highlights the transformative potential of Cellino's automated technology for scaling up high-quality iPSCs to industrialize next-generation regenerative therapies.
The FDA encourages the adoption of advanced manufacturing technologies (AMTs) that improve manufacturing reliability, product quality, and production scale. The AMT designation accelerates timelines for therapies manufactured using Cellino's optical biomanufacturing technology, offering higher priority within the FDA, along with earlier and more frequent interactions during Investigational New Drug (IND), New Drug Application (NDA), and Biologics License Application (BLA) processes for a faster path to market.
'We are honored to receive the AMT designation for our proprietary technology stack,' said Nabiha Saklayen, Ph.D., CEO and Co-Founder of Cellino. 'This recognition affirms our commitment to revolutionizing the production of patient-specific iPSCs, enabling faster and more consistent clinical and commercial-scale manufacturing. It's a pivotal moment in our mission to deliver personalized regenerative therapies that can scale globally, transforming healthcare for millions.'
Autologous iPSC manufacturing has long been one of the most complex challenges in biomanufacturing, involving labor-intensive processes like manual passaging and colony picking that only a limited number of experts worldwide can perform. These hurdles have slowed progress, preventing many therapeutic programs from advancing past early-phase clinical trials. Cellino's proprietary optical bioprocessing technology overcomes these challenges by introducing precision, reproducibility, and scalability, ensuring reliable, high-quality iPSC production for both clinical trials and commercial stages.
'This AMT designation underscores the scientific rigor and transformative potential of our technology,' said Marinna Madrid, Ph.D., Chief Product Officer and Co-Founder of Cellino. 'Automated, optical manufacturing is key to ensuring patient access to regenerative medicines. This milestone brings us closer to scaling therapies from Phase 1 through large-scale commercialization, aiming to address some of the world's most debilitating chronic degenerative diseases.'
Cellino intends to leverage the AMT designation to expedite the translation of personalized iPSC-derived therapies into clinical practice. With global chronic disease burdens rising and more than 100 million individuals in the U.S. alone who could potentially benefit from iPSC-derived therapies, Cellino's technology is poised to significantly expand patient access to next-generation living medicines.
For more information on the FDA's Advanced Manufacturing Technologies Designation Program, visit the FDA AMT Guidance.
About Cellino
Cellino is a leader in advanced biomanufacturing technology, committed to making personalized cell, tissue, and organ replacements a reality for patients around the world. Learn more at www.cellinobio.com and follow us on LinkedIn and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
American Water Appoints New Independent Member to the Board of Directors
CAMDEN, N.J., June 09, 2025--(BUSINESS WIRE)--American Water Works Company, Inc. (NYSE: AWK) announced today that Raffiq Nathoo has been appointed as an independent member of the company's board of directors, effective today. "American Water is pleased to have Raffiq join our board of directors," said Karl Kurz, Board Chair of American Water. "Bringing more than 30 years of experience in the international financial and capital markets, including leadership in the energy, power and utilities sectors, Raffiq will further strengthen our board, and we look forward to working with him." "We are honored to have Raffiq become part of American Water's board," said John Griffith, President and CEO of American Water. "His deep expertise in utility sector finance will bring great value to the board and our company." Nathoo has served as a Managing Partner of Tx3 Sage Rock, a private investment management firm, since August 2019. His professional experience in investment banking and private and public equity businesses, includes work with New Mountain Capital, where he served as an Executive-in-Residence from 2015 to 2017, and with Blackstone from 1991 to 2014, where he was a Senior Managing Director for 14 years and led the firm's advisory practice globally in the energy, power and utilities sectors. He currently serves on the Board of Directors of Cabot Corporation (NYSE: CBT), a specialty chemicals and performance materials company, where he is a member of the Audit Committee. Nathoo earned an MBA from Harvard University and a Bachelor of Arts degree in Government from Dartmouth College. American Water's board of directors now consists of nine members. About American Water American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to more than 14 million people with regulated operations in 14 states and on 18 military installations. American Water's 6,700 talented professionals leverage their significant expertise and the company's national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders. For more information, visit and join American Water on LinkedIn, Facebook, X and Instagram. AWK-IR View source version on Contacts Investors: Aaron MusgraveVice President, Investor Relations(856) Media: Maureen DuffyExecutive Vice President, Communications and External Affairs(856) Error in retrieving data Sign in to access your portfolio Error in retrieving data
Business Wire
26 minutes ago
- Business Wire
Albany International to Present at the Wells Fargo 2025 Industrials & Materials Conference
ROCHESTER, N.H.--(BUSINESS WIRE)--Albany International Corp. (NYSE:AIN) President and Chief Executive Officer, Gunnar Kleveland, will speak at the Wells Fargo 2025 Industrials & Materials Conference on Wednesday, June 11, 2025 at 4:45 p.m. ET. Interested parties are invited to listen to the webcast via the Company's Investor Relations website at A replay of the webcast will be available on the website following the event. About Albany International Corp. Albany International is a leading developer and manufacturer of engineered components, using advanced materials processing and automation capabilities, with two core businesses. Machine Clothing is the world's leading producer of custom-designed, consumable belts essential for the manufacture of paper, paperboard, tissue and towel, pulp, non-wovens and a variety of other industrial applications. Albany Engineered Composites is a growing designer and manufacturer of advanced materials‑based engineered components for demanding aerospace applications, supporting both commercial and military platforms. Albany International is headquartered in Rochester, New Hampshire, operates 30 facilities in 13 countries, employs approximately 5,400 people worldwide, and is listed on the New York Stock Exchange (Symbol: AIN). Additional information about the Company and its products and services can be found at
Yahoo
26 minutes ago
- Yahoo
Albany International to Present at the Wells Fargo 2025 Industrials & Materials Conference
ROCHESTER, N.H., June 09, 2025--(BUSINESS WIRE)--Albany International Corp. (NYSE:AIN) President and Chief Executive Officer, Gunnar Kleveland, will speak at the Wells Fargo 2025 Industrials & Materials Conference on Wednesday, June 11, 2025 at 4:45 p.m. ET. Interested parties are invited to listen to the webcast via the Company's Investor Relations website at A replay of the webcast will be available on the website following the event. About Albany International Corp. Albany International is a leading developer and manufacturer of engineered components, using advanced materials processing and automation capabilities, with two core businesses. Machine Clothing is the world's leading producer of custom-designed, consumable belts essential for the manufacture of paper, paperboard, tissue and towel, pulp, non-wovens and a variety of other industrial applications. Albany Engineered Composites is a growing designer and manufacturer of advanced materials‑based engineered components for demanding aerospace applications, supporting both commercial and military platforms. Albany International is headquartered in Rochester, New Hampshire, operates 30 facilities in 13 countries, employs approximately 5,400 people worldwide, and is listed on the New York Stock Exchange (Symbol: AIN). Additional information about the Company and its products and services can be found at View source version on Contacts Investor / Media Contact: JC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
